A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent musi mieć ukończone 18 lat.
- •Pacjent musi mieć potwierdzoną biopsją zaawansowaną, nieoperacyjną lub przerzutową postać litego nowotworu.
- •Stan pacjenta musi być stabilny, pozwalający na normalne codzienne funkcjonowanie (grupa sprawności ECOG 0 lub 1).
- •U pacjentek z rakiem jajnika, nowotwór musi wykazywać specyficzne cechy genetyczne (amplifikacja CCNE1) – dotyczy tylko części badania 2A.
✗ Disqualifies
- •Pacjent nie może mieć aktywnego przerzutu do mózgu.
- •Pacjent nie może mieć problemów z pracą serca.
- •Pacjent nie może mieć zaburzeń krzepnięcia krwi ani znaczących krwawień w ciągu ostatnich 3 miesięcy.
- •Pacjent nie może mieć uszkodzenia nerwów obwodowych stopnia 2 lub wyższego.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 2, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (21)
University of Alabama at Birmingham
Birmingham, United States
Providence St. Jude Medical Center
Fullerton, United States
Marin Cancer Care
Greenbrae, United States
Moores Cancer Center
La Jolla, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, United States
Local Institution - 0008
Aurora, United States
Dana-Farber Cancer Institute
Boston, United States
Washington University School of Medicine
St Louis, United States
Dartmouth-Hitchcock Medical Center
Lebanon, United States
Roswell Park Cancer Institute
Buffalo, United States
Northwell Health-Cancer Institute
New Hyde Park, United States
Local Institution - 0011
New York, United States
Memorial Sloan Kettering Cancer Center
New York, United States
START Dallas Fort Worth
Fort Worth, United States
NEXT Oncology
San Antonio, United States
Odense Universitetshospital
Odense, Denmark
Copenhagen University Hospital
Copenhagen, Denmark
National Cancer Center Hospital East
Kashiwa, Japan
Kansai Medical University Hospital
Hirakata, Japan
National Cancer Center Hospital
Chuo-ku, Japan
The Cancer Institute Hospital of JFCR
Koto-ku, Japan
Trial contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com, www.BMSStudyConnect.com
First line of the email MUST contain NCT # and Site #.
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.